- $34.50m
- $13.75m
- $13.85m
- 25
- 46
- 39
- 30
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.88 | ||
Price to Tang. Book | 1.67 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.99 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -57.04% | ||
Return on Equity | -46.26% | ||
Operating Margin | -143.74% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 4.87 | 4.39 | 5.97 | 5.51 | 13.85 | 30.82 | 58.27 | 16.18% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Directors
- Jeff Dykan NEC (62)
- Ori Gon CFO (38)
- Jeannine Lynch VPR
- Lawrence Jasinski DRC (63)
- Aryeh Dan IND (62)
- Yohanan Engelhardt IND (63)
- Yasushi Ichiki IND (53)
- John Poduska IND (83)
- Randel Richner IND (65)
- Wayne Weisman IND (65)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- June 20th, 2001
- Public Since
- September 12th, 2014
- No. of Employees
- 108
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 8,602,626
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 3 Hatnufa st. 6th fl.,, YOKNEAM, 2069203
- Web
- https://golifeward.com/
- Phone
- +972 49590123
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for LFWD
Rewalk Robotics Ltd Annual Shareholders Meeting
Q3 2024 Rewalk Robotics Ltd Earnings Release
Similar to LFWD
Accelerate Diagnostics
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Agendia NV
NASDAQ Capital Market
FAQ
As of Today at 22:58 UTC, shares in Rewalk Robotics are trading at $4.14. This share price information is delayed by 15 minutes.
Shares in Rewalk Robotics last closed at $4.14 and the price had moved by +0.14% over the past 365 days. In terms of relative price strength the Rewalk Robotics share price has underperformed the S&P500 Index by -20.32% over the past year.
The overall consensus recommendation for Rewalk Robotics is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Rewalk Robotics does not currently pay a dividend.
Rewalk Robotics does not currently pay a dividend.
Rewalk Robotics does not currently pay a dividend.
To buy shares in Rewalk Robotics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.14, shares in Rewalk Robotics had a market capitalisation of $35.61m.
Here are the trading details for Rewalk Robotics:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: LFWD
Based on an overall assessment of its quality, value and momentum Rewalk Robotics is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Rewalk Robotics is $13.00. That is 214.01% above the last closing price of $4.14.
Analysts covering Rewalk Robotics currently have a consensus Earnings Per Share (EPS) forecast of -$1.94 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rewalk Robotics. Over the past six months, its share price has underperformed the S&P500 Index by -27.2%.
As of the last closing price of $4.14, shares in Rewalk Robotics were trading -23.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rewalk Robotics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rewalk Robotics' management team is headed by:
- Jeff Dykan - NEC
- Ori Gon - CFO
- Jeannine Lynch - VPR
- Lawrence Jasinski - DRC
- Aryeh Dan - IND
- Yohanan Engelhardt - IND
- Yasushi Ichiki - IND
- John Poduska - IND
- Randel Richner - IND
- Wayne Weisman - IND